<DOC>
	<DOC>NCT01050452</DOC>
	<brief_summary>This randomised, controlled, double-blinded clinical study investigates the safety and efficacy of albendazole (ALB), mebendazole (MBD) and ivermectin (IVM) separately, and ALB and MBD each in combination with IVM in the treatment of Trichuris trichiura in children aged 5-14 years.</brief_summary>
	<brief_title>Safety and Efficacy of Drug Combinations Against Trichuris Trichiura</brief_title>
	<detailed_description />
	<mesh_term>Parasitic Diseases</mesh_term>
	<mesh_term>Albendazole</mesh_term>
	<mesh_term>Mebendazole</mesh_term>
	<mesh_term>Piperazine</mesh_term>
	<mesh_term>Piperazine citrate</mesh_term>
	<mesh_term>Ivermectin</mesh_term>
	<criteria>Those who are enrolled in class one to six Are infected with T. trichiura Whose parent consent and who are willing to participate Those with acute and chronic diseases other than T. trichiura Those with a history of any serious adverse drug reactions</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>